PI-3,4-P2, 5NH4, PIP2, Dipalmitoyl-

PI-3,4-P2, also known as phosphatidylinositol 3,4-bisphosphate, is a crucial signaling lipid involved in various cellular processes, prominently in cell signaling cascades and membrane trafficking. Its mechanism of action lies in its ability to serve as a secondary messenger by modulating the activity of numerous effector proteins, thereby regulating key cellular functions. PI-3,4-P2 exerts its effects through interactions with specific protein domains, such as pleckstrin homology (PH) domains found in various signaling proteins. Upon stimulation of cell surface receptors, PI-3,4-P2 is generated through the phosphorylation of phosphatidylinositol 4-phosphate (PI-4-P) by phosphoinositide 3-kinase (PI3K). Once formed, PI-3,4-P2 recruits and activates downstream effector proteins, including Akt and PDK1, leading to the activation of multiple signaling pathways, such as the PI3K/Akt/mTOR pathway, which regulates cell survival, proliferation, and metabolism. In research, PI-3,4-P2 plays a pivotal role in elucidating the signaling networks governing cellular physiology and pathology. Studies utilize synthetic analogs or enzymatic assays to investigate the functions of PI-3,4-P2 and its impact on cellular processes. Moreover, research efforts focus on understanding the regulation of PI-3,4-P2 levels and its dysregulation in various diseases, including cancer, diabetes, and neurological disorders. By unraveling the mechanisms underlying PI-3,4-P2 signaling, researchers aim to identify novel targets and develop strategies for treating diseases associated with aberrant phosphoinositide signaling pathways.